manual-prevencion

MANUAL SEOM DE PREVENCIÓN Y DIAGNÓSTICO PRECOZ DEL CÁNCER 230 5. BIBLIOGRAFÍA 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, RebeloM, et al. Cancer incidence andmortality worldwide: Sources, methods andmajor patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):E359-E86. 2. Cifras del Cáncer en España 2016. Sociedad Española de Oncología Médica. http://www.seom.org/en/prensa/el-cancer-en- espanyacom/105460-el-cancer-en-espana-2016 . 3. Seijas-TamayoR, Fernández-Mateos J, AdansaKlainJC,MesíaR, Pastor BorgoñónM, Pérez-RuizE, et al. Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location. Clinical andTranslational Oncology. 2016;18(11):1114-22. 4. Shanmugaratnam K SL. Histological typing of tumors of the upper respiratory tract and ear. En: Shanmugaratnam K SL, editor. Geneve: WHO; 1991. 5. Pignon J-P, Maître Al, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology. 2009;92(1):4-14. 6. Wyss A, Hashibe M, Chuang SC, Lee YCA, Zhang ZF, Yu GP, et al. Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head andNeck Cancer Epidemiology Consortium. American Journal of Epidemiology. 2013;178(5):679-90. 7. Berthiller J, Straif K, AgudoA, AhrensW, Bezerra dos Santos A, Boccia S, et al. Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortiumpooled analysis. International Journal of Epidemiology. 2016;45(3):835-45. 8. Zuo-FengZhang, HalMorgenstern,Margaret R. Spitz, DonaldP.Tashkin, Guo-PeiYu,TaoC. HsuandStimsonP. Schantz. Environmental Tobacco Smoking, Mutagen Sensitivity, and Head and Neck Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 2000;9:1043-1049 9. Lee YCA, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J, et al. Involuntary Smoking and Head and Neck Cancer Risk: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology Biomarkers & Prevention. 2008;17(8):1974-81. 10. Berthiller J, Lee YcA, Boffetta P, Wei Q, Sturgis EM, Greenland S, et al. Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium. Cancer Epidemiology Biomarkers & Prevention. 2009;18(5):1544-51. 11. BagnardiV, RotaM, Botteri E,Tramacere I, Islami F, FedirkoV, et al. Alcohol consumptionandsite-specificcancer risk: acomprehensive dose–response meta-analysis. British Journal of Cancer. 2014;112(3):580-93. 12. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Light alcohol drinking and cancer: a meta-analysis. Annals of Oncology. 2012;24(2):301-8. 13. Islami F, Tramacere I, Rota M, Bagnardi V, Fedirko V, Scotti L, et al. Alcohol drinking and laryngeal cancer: Overall and dose–risk relation – A systematic review andmeta-analysis. Oral Oncology. 2010;46(11):802-10. 14. Purdue MP, Hashibe M, Berthiller J, La Vecchia C, Maso LD, Herrero R, et al. Type of Alcoholic Beverage and Risk of Head and Neck Cancer--A Pooled AnalysisWithin the INHANCE Consortium. American Journal of Epidemiology. 2008;169(2):132-42. 15. Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: A case-control study. Oral Oncology. 2010;46(4):297-301. 16.D’SouzaG, KreimerAR,Viscidi R, PawlitaM, FakhryC, KochWM, etal. Case-control studyofhumanpapillomavirusandoropharyngeal cancer. The New England journal of medicine. 2007;356(19):1944-56. 17. Marur S, D’Souza G, WestraWH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology. 2010;11(8):781-9. 18. D’Souza G, Anantharaman D, Gheit T, Abedi-Ardekani B, Beachler DC, Conway DI, et al. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents. Oral Oncology. 2016;62:20-7. 19. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC monographs on the evaluation of carcinogenic risks to humans. 1997;70:1-492. 20. Conway DI, Brenner DR, McMahon AD, Macpherson LMD, Agudo A, Ahrens W, et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. International Journal of Cancer. 2015;136(5):1125-39. 21. Gaudet MM, Olshan AF, Chuang SC, Berthiller J, Zhang ZF, Lissowska J, et al. Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. International Journal of Epidemiology. 2010;39(4):1091-102. 22. Ward HA, Wark PA, Muller DC, Steffen A, Johansson M, Norat T, et al. Measured adiposity in relation to head and neck cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology Biomarkers & Prevention. 2017:cebp.0886.2016. 23. GaravelloW. Body size and laryngeal cancer risk. Annals of Oncology. 2006;17(9):1459-63.